Search
  • Contact Us
  • Careers
Menu
  • Contact Us
  • Careers
Applied Therapeutics logo
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
Applied Therapeutics logo
Applied Therapeutics logo
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Careers
    • Mission
    • Culture
      • Diversity & Inclusion
    • Contact Us
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Understanding Diabetic Cardiomyopathy
    • Understanding Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor FAQs
    • Email Alerts
    • Investor Contacts
Applied Therapeutics logo
Executive Leadership Team
CEO & Founder Shoshana Shendelman

Shoshana Shendelman

CEO & Founder

Chief Medical Officer Riccardo Perfetti

Riccardo Perfetti

Chief Medical Officer

Chief Financial Officer Charles Silberstein

Charles Silberstein

Chief Financial Officer

Chief Commercial Officer Adam Hansard

Adam Hansard

Chief Commercial Officer

Leadership

  • Executive Leadership
  • Board of Directors
  • Scientific Advisory Board
Menu
  • Executive Leadership
  • Board of Directors
  • Scientific Advisory Board

In the about us section

BehindBottomNav-SmallerSwoosh-min
Swoosh Background-min
Leadership
Mission
Culture
Contact
Applied Therapeutics logo
  • About Us
  • Pipeline
  • Patients & Caregivers
  • Investors & Media
Menu
  • About Us
  • Pipeline
  • Patients & Caregivers
  • Investors & Media
  • Terms of Use
  • Privacy Policy
Linkedin
Facebook-square
Twitter-square

©2020 Applied Therapeutics All Rights Reserved

Linkedin
Facebook-square
Twitter-square
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
Menu
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
  • Terms of Use
  • Privacy Policy
Applied Therapeutics logo

©2020 Applied Therapeutics All Rights Reserved